Locally Late-stage HCC: Integrating HAIC into First-line Treatment

Wednesday, April 15, 2026

10:39 AM - 10:48 AM ET

Location: 715

Speaker(s)

QZ

Qi Zhang, MD, PhD

None
Zhongda Hospital, Southeast University, Jiangsu, China (People's Republic)
Haibo Shao, MD, PhD

Director of IR Department
The First Hospital of China Medical University, Liaoning, China (People's Republic)

To explore the increasing role of local therapies in liver tumors and the importance to integrate IO into clinical care.